Showing results (401-410 of 546) with videos related to
Sort By:
Pageof 55
BMC Pediatrics|August 20, 2020
Home-based intervention for non-Hispanic black families finds no significant difference in infant size or growth: results from the Mothers & Others randomized controlled trialHeather M Wasser, Amanda L Thompson, Chirayath M Suchindran, et al.Journal of Anxiety Disorders|November 21, 2023
Exposure traced in daily life: improvements in ecologically assessed social and physical activity following exposure-based psychotherapy for anxiety disordersIngmar Heinig, Martin Weiß, Alfons O Hamm, et al.Clinical Pharmacokinetics|November 13, 2021
Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event AnalysisPaul van den Berg, Martijn Ruppert, Emir Mesic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumorsKlaus Mross, Annette Frost, Simone Steinbild, et al.ACS Nano|August 28, 2018
Highly Conducting Hybrid Silver-Nanowire-Embedded Poly(3,4-ethylenedioxythiophene):Poly(styrenesulfonate) for High-Efficiency Planar Silicon/Organic Heterojunction Solar CellsJoseph P Thomas, Md Anisur Rahman, Saurabh Srivastava, et al.Multiple Sclerosis and Related Disorders|July 21, 2018
An MRI evaluation of grey matter damage in African Americans with MSMaria Petracca, Wafaa Zaaraoui, Sirio Cocozza, et al.Clinical Pharmacokinetics|May 6, 2023
Estimation of FMO3 Ontogeny by Mechanistic Population Pharmacokinetic Modelling of Risdiplam and Its Impact on Drug-Drug Interactions in ChildrenYumi Cleary, Heidemarie Kletzl, Paul Grimsey, et al.British Journal of Cancer|May 10, 2012
Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I studyD Strumberg, M E Scheulen, B Schultheis, et al.Scientific Reports|May 19, 2017
Acquisition of virulence factors in livestock-associated MRSA: Lysogenic conversion of CC398 strains by virulence gene-containing phagesBritta Kraushaar, Jens Andre Hammerl, Marina Kienöl, et al.Gigascience|June 15, 2018
MetaMap: an atlas of metatranscriptomic reads in human disease-related RNA-seq dataL M Simon, S Karg, A J Westermann, et al.Pageof 55